About Brainvectis

About company

Brainvectis is focused on the development of treatments that focus on neurodegenerative diseases such as Huntington’s and Alzheimer’s diseases. It researches about the restoration of brain cholesterol metabolism by increasing CYP46A1 in the patients’ brains. Brainvectis was founded by Nathalie Cartier Lacave in 2015. It is based in Fontenay-aux-Roses, France.